Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Peter Doshi & Tom Jefferson & Chris Del Mar, 2012. "The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience," PLOS Medicine, Public Library of Science, vol. 9(4), pages 1-6, April.
- Travis K. Warren & Robert Jordan & Michael K. Lo & Adrian S. Ray & Richard L. Mackman & Veronica Soloveva & Dustin Siegel & Michel Perron & Roy Bannister & Hon C. Hui & Nate Larson & Robert Strickley , 2016. "Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys," Nature, Nature, vol. 531(7594), pages 381-385, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Francetic, Igor, 2021. "Bad law or implementation flaws? Lessons from the implementation of the new law on epidemics during the response to the first wave of COVID-19 in Switzerland," Health Policy, Elsevier, vol. 125(10), pages 1285-1290.
- Frederic Bouder & Dominic Way & Ragnar Löfstedt & Darrick Evensen, 2015. "Transparency in Europe: A Quantitative Study," Risk Analysis, John Wiley & Sons, vol. 35(7), pages 1210-1229, July.
- Ropo E. Ogunsakin & Oluwakemi Ebenezer & Maryam A. Jordaan & Michael Shapi & Themba G. Ginindza, 2022. "Mapping Scientific Productivity Trends and Hotspots in Remdesivir Research Publications: A Bibliometric Study from 2016 to 2021," IJERPH, MDPI, vol. 19(14), pages 1-22, July.
- Farah Daou & Gretta Abou-Sleymane & Danielle A. Badro & Nagham Khanafer & Mansour Tobaiqy & Achraf Al Faraj, 2021. "The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19," IJERPH, MDPI, vol. 18(3), pages 1-16, January.
- Jade Mitchell & Kara Dean & Charles Haas, 2020. "Ebola Virus Dose Response Model for Aerosolized Exposures: Insights from Primate Data," Risk Analysis, John Wiley & Sons, vol. 40(11), pages 2390-2398, November.
More about this item
Keywords
SARS-CoV-2; clinical ethics; pharmaceutical preparations; public health; epidemic; disease outbreak;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:11:p:5685-:d:562353. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.